Probachai, Volodymyr External Entity

Publications

Sort by

Selected publications

  • Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.  Lancet2012 Academic Article GET IT
    Times cited: 595

Other